-DOCSTART- -X- O
PURPOSE -X- _ O
OF -X- _ O
REVIEW -X- _ O
: -X- _ O
Middle -X- _ B-Patient
East -X- _ I-Patient
respiratory -X- _ I-Patient
syndrome -X- _ I-Patient
coronavirus -X- _ I-Patient
( -X- _ I-Patient
MERS-CoV -X- _ I-Patient
) -X- _ I-Patient
emerged -X- _ O
in -X- _ O
2012 -X- _ O
and -X- _ O
is -X- _ O
listed -X- _ O
in -X- _ O
the -X- _ O
World -X- _ O
Health -X- _ O
Organizationâ€™s -X- _ O
blueprint -X- _ O
of -X- _ O
priority -X- _ O
diseases -X- _ O
that -X- _ O
need -X- _ O
immediate -X- _ O
research. -X- _ O
Camels -X- _ O
are -X- _ O
reservoirs -X- _ O
of -X- _ O
this -X- _ O
virus -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
virus -X- _ O
spills -X- _ O
over -X- _ O
into -X- _ O
humans -X- _ O
through -X- _ O
direct -X- _ O
contact -X- _ O
with -X- _ O
camels. -X- _ O
Human-to-human -X- _ O
transmission -X- _ O
and -X- _ O
travel-associated -X- _ O
cases -X- _ O
have -X- _ O
been -X- _ O
identified -X- _ O
as -X- _ O
well. -X- _ O
Limited -X- _ O
studies -X- _ O
have -X- _ O
characterized -X- _ O
the -X- _ O
molecular -X- _ O
pathogenesis -X- _ O
of -X- _ O
MERS-CoV. -X- _ O
Most -X- _ O
studies -X- _ O
have -X- _ O
used -X- _ O
ectopic -X- _ O
expression -X- _ O
of -X- _ O
viral -X- _ O
proteins -X- _ O
to -X- _ O
characterize -X- _ O
MERSCoV -X- _ B-Patient
and -X- _ O
its -X- _ O
ability -X- _ O
to -X- _ O
modulate -X- _ O
antiviral -X- _ O
responses -X- _ O
in -X- _ O
human -X- _ O
cells. -X- _ O
Studies -X- _ O
with -X- _ O
live -X- _ O
virus -X- _ O
are -X- _ O
limited -X- _ O
, -X- _ O
largely -X- _ O
due -X- _ O
to -X- _ O
the -X- _ O
requirement -X- _ O
of -X- _ O
high -X- _ O
containment -X- _ O
laboratories. -X- _ O
In -X- _ O
this -X- _ O
review -X- _ O
, -X- _ O
we -X- _ O
have -X- _ O
summarized -X- _ O
current -X- _ O
studies -X- _ O
on -X- _ O
MERS-CoV -X- _ O
molecular -X- _ O
pathogenesis -X- _ O
and -X- _ O
have -X- _ O
mentioned -X- _ O
some -X- _ O
recent -X- _ O
strategies -X- _ O
that -X- _ O
are -X- _ O
being -X- _ O
developed -X- _ O
to -X- _ O
control -X- _ O
MERS-CoV -X- _ O
infection. -X- _ O
RECENT -X- _ O
FINDINGS -X- _ O
: -X- _ O
Multiple -X- _ B-Outcome
antiviral -X- _ I-Outcome
molecules -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
potential -X- _ I-Outcome
to -X- _ I-Outcome
inhibit -X- _ I-Outcome
MERS-CoV -X- _ I-Outcome
infection -X- _ I-Outcome
by -X- _ I-Outcome
disrupting -X- _ I-Outcome
virusreceptor -X- _ I-Outcome
interactions -X- _ I-Outcome
are -X- _ I-Outcome
being -X- _ I-Outcome
developed -X- _ I-Outcome
and -X- _ I-Outcome
tested. -X- _ I-Outcome
Although -X- _ I-Outcome
human -X- _ I-Outcome
vaccine -X- _ I-Outcome
candidates -X- _ I-Outcome
are -X- _ I-Outcome
still -X- _ I-Outcome
being -X- _ I-Outcome
developed -X- _ I-Outcome
, -X- _ I-Outcome
a -X- _ I-Outcome
candidate -X- _ I-Outcome
camel -X- _ I-Outcome
vaccine -X- _ I-Outcome
is -X- _ I-Outcome
being -X- _ I-Outcome
tested -X- _ I-Outcome
for -X- _ I-Outcome
efficacy. -X- _ I-Outcome
Combination -X- _ I-Outcome
of -X- _ I-Outcome
supportive -X- _ I-Outcome
treatment -X- _ I-Outcome
with -X- _ I-Outcome
interferon -X- _ I-Outcome
and -X- _ I-Outcome
antivirals -X- _ I-Outcome
is -X- _ I-Outcome
also -X- _ I-Outcome
being -X- _ I-Outcome
explored. -X- _ I-Outcome
SUMMARY -X- _ O
: -X- _ O
New -X- _ O
antiviral -X- _ O
molecules -X- _ O
that -X- _ O
inhibit -X- _ O
MERS-CoV -X- _ O
and -X- _ O
host -X- _ O
cell -X- _ O
receptor -X- _ O
interaction -X- _ O
may -X- _ O
become -X- _ O
available -X- _ O
in -X- _ O
the -X- _ O
future. -X- _ O
Additional -X- _ O
studies -X- _ O
are -X- _ O
required -X- _ O
to -X- _ O
identify -X- _ O
and -X- _ O
characterize -X- _ O
the -X- _ O
pathogenesis -X- _ O
of -X- _ O
MERS-CoV -X- _ O
EMC -X- _ O
/ -X- _ O
2012 -X- _ O
and -X- _ O
other -X- _ O
circulating -X- _ O
strains. -X- _ O
An -X- _ O
effective -X- _ O
MERS-CoV -X- _ O
vaccine -X- _ O
, -X- _ O
for -X- _ O
humans -X- _ O
and -X- _ O
/ -X- _ O
or -X- _ O
camels -X- _ O
, -X- _ O
along -X- _ O
with -X- _ O
an -X- _ O
efficient -X- _ O
combination -X- _ O
antiviral -X- _ O
therapy -X- _ O
may -X- _ O
help -X- _ O
us -X- _ O
prevent -X- _ O
future -X- _ O
MERS -X- _ O
cases -X- _ O
. -X- _ O

